Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study will recruit 40 HS patients with an abscess and inflammatory nodule (AN) count≥5 at a single body site (ex. bilateral axillae, medial thighs). Participants will berandomized 1:1 to receive placebo or 50U of BoNT per 100cm2 of skin (100U total)administered twice over a 6‐month study period. Randomization will be stratified bydisease stage (Hurley stage
Epistemonikos ID: 8621e943c9b32afc24935d773d31618ad7bb6f4f
First added on: Aug 11, 2026